Key points are not available for this paper at this time.
TAFRO syndrome is a systemic inflammatory, lymphoproliferative disorder, but the pathophysiology of the disease is unknown. It is typically characterized by thrombocytopenia, anasarca, a fever, reticulin fibrosis, renal dysfunction, and organomegaly. However, other manifestations have been also reported. We encountered a 43-year-old man with TAFRO syndrome who showed mediastinal panniculitis, liver damage, and adrenal lesions in addition to the core signs. He achieved complete remission with combination therapy of corticosteroids, tocilizumab, and cyclosporin, and remission was maintained even after drug discontinuation at 15 months. Atypical manifestations and complete remission of TAFRO syndrome were remarkable features of our case.
Building similarity graph...
Analyzing shared references across papers
Loading...
Shiro Ono
Nara Medical University Hospital
Kiyomi Yoshimoto
Nara Medical University Hospital
Nobushiro Nishimura
Nara Medical University Hospital
Internal Medicine
Nara Medical University
Building similarity graph...
Analyzing shared references across papers
Loading...
Ono et al. (Sun,) studied this question.
synapsesocial.com/papers/6a0230c58b14fde368dcf2ab — DOI: https://doi.org/10.2169/internalmedicine.5850-20